Today marks the beginning of 2019’s National Drug and Alcohol Facts Week, a health observance first launched by the National Institute on Drug Abuse (NIDA) in 2010. In 2016, the National Institute of Alcohol Abuse and Alcoholism became a partner, adding alcohol as a topic area for the week. Geared towards teens, the initiative helps educate people on what science has taught us about drug addiction and alcohol. It also attempts to debunk myths that teens–and adults–may believe about certain substances due to various influences such as social media, peers, music, movies, and TV shows.
The good folks over at Caveat, New York City’s lounge for “intelligent nightlife,” have once again managed to provide knowledge-seekers an evening of fun and discovery through stimulating presentations, this time under the Nerd Nite banner, hosted by Matt Wasowski.
As the organization’s curator and self-proclaimed “Big Boss” Wasowski was quick to describe Nerd Nite as “the Discovery Channel with beer”—an accurate analogy for their cross-discipline presentations that take place in bars in over 100 cities around the world. The performance at Caveat included three presentations for the evening.
Each speaker brought with them a different topic and different flow to the evening, some more humorous and some more solemn. Brice Particelli, Ph.D., and Chris Cummins both provided amusing, food-for-thought talks on stage, discussing how creationists successfully use genre to promote “alternative” facts and trying to untangle exactly how the cultural marvel of “The Fonz” came to pass.
In a presentation with more gravitas, guest speaker Jay Stahl-Herz, M.D., a forensic pathologist and medical examiner, offered the audience a sobering look at the opioid epidemic currently ravaging America, using an informative and (at times) devastating presentation to elaborate on the drug overdose crisis. Continue reading
“We’ve moved from an epidemic to a crisis” in opioid abuse in the United States, said Daniel Ciccarone, M.D., MPH, during a panel discussion at AAAS in Washington, DC, this week. Ciccarone, a doctor at University of California, San Francisco, who treats addicted people and does research, described a pattern of intertwined waves involving abuse of prescription pills, heroin, and synthetic opioids like fentanyl.
For example, while overdose deaths due to prescription pill use are spread relatively evenly across the country, “this is not true for heroin,” Ciccarone said. The Northeast has had troubles with opioid abuse for a generation, while in the Midwest, numbers have jumped just recently. And while older folks (50-64) are using pills in greater numbers, it’s younger people (20-35) driving heroin use.
“Heroin itself is becoming more and more dangerous,” he said, especially when it is laced with synthetic drugs like fentanyl and carfentanil (used to tranquilize elephants). People who stop breathing after using these stronger concoctions often don’t respond to emergency treatments like naloxone.
Opioid addiction has reached epidemic proportions in the United States, with overdoses and deaths caused by prescribed and “street” drugs on the rise. The accelerating abuse of opioids includes not only painkillers that have legitimate uses, but heroin and the synthetic opioid fentanyl as well. The epidemic is not limited to inner city pockets of poverty; small-town America is also overcome by a tsunami of opioid addiction, putting strains on state and local social services and criminal justice systems. Join us for an event that will address the demographics and sociology of the opioid epidemic, the science of opioid addiction, and treatment options.
It is estimated that between 26.4 million and 36 million people abuse opioids worldwide; the US government estimates that 2.1 million people in the United States have substance use disorders related to prescription opioid pain relievers in 2012 and another 467,000 are addicted to heroin. Consequences include a spike in the number of unintentional overdose deaths from prescription pain relievers (including the recent death of the musician Prince), and growing evidence to suggest a relationship between increased non-medical use of opioid analgesics and heroin abuse in the US.
What can we do to help? This spring, Charles O’Brien and colleagues reported results of the latest in a series of studies testing the drug naltrexone as a preventive against opioid relapse in people greatly at risk for relapse: formerly addicted convicts. “This U.S. multisite, open-label, randomized effectiveness trial showed that among adult offenders who had a history of opioid dependence, the rate of relapse was lower among participants assigned to extended-release naltrexone than among those assigned to usual treatment,” they write.